Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE ...

From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

However, early success with HIV-to-HIV kidney transplantation alleviated these concerns. Publishing in the New England Journal of Medicine online Oct. 17, researchers analyzed the outcomes for 198 ...

A UNM researcher and assistant professor is breaking barriers in the health community for fellow Native Americans. Hailing ...

The article, Safety of Kidney Transplantation from Donors with HIV, details findings supporting HIV-to-HIV kidney transplants as safe and just as effective as those using organs from donors without ...

The supply of health care professionals available to provide HIV care is expected to continue to decline over the next ...

For a study published in HIV Medicine, the researchers conducted a cross-sectional retrospective analysis of four cohorts of ...

How trustworthy is a positive HIV test result? How probable is an actual infection when the test is positive? Even ...

A recent study reveals that nearly 20% of United States physicians treating HIV patients plan to leave or reduce their ...

NIH-funded research offers evidence on transplantation practices that are currently confined to research environments. A ...

On her way home from the hospital in Nkhoma in rural Malawi, the headlight beam from Jacqueline’s motorbike falls on ...